Home › Amyloidosis › Kansas
Amyloidosis clinical trials in Kansas
3 studies for Amyloidosis are looking for participants at sites in Kansas.
Cities in Kansas
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Kansas City
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 16, 2026 · NCT07052903DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
- Clinical Trial Site, Kansas City
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07358078ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- Clinical Trial Site, Kansas City
RecruitingObservational study
All ages · All sexes · Updated Sep 8, 2026 · NCT04561518From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.